Attached files
file | filename |
---|---|
8-K/A - 8-KA #1 - Rich Pharmaceuticals, Inc. | rcha8ka02082016.htm |
EX-99.1 - EXHIBIT 99.1 - Rich Pharmaceuticals, Inc. | ex99_1.htm |
BARBARA K. CEGAVSKE Secretary of State 206 North Carson Street Carson City, Nevada 89701-4299 (775) 684 5708 Website: secretaryofstate.biz |
|
Certificate
of Change Pursuant to NRS 78.209 | |
USE BLACK INK ONLY – DO NOT HIGHLIGHT | ABOVE SPACE IS FOR OFFICE USE ONLY |
Certificate
of Change filed Pursuant to NRS 78.209 For Nevada Profit Corporations | |
1. Name of corporation: | |
Rich Pharmaceuticals, Inc. | |
2. The board of directors have adopted a resolution pursuant to NRS 78.209 and have obtained any required approval of the stockholders. | |
3. The current number of authorized shares at the par value, if any, of each class or series, if any, of shares before the change: | |
37,503,000,000 shares of common stock authorized, $0.001 par value 10,000,000 shares of preferred stock authorized, $0.001 par value | |
4. The number of authorized shares and the par value, if any, of each class or series, if any, of shares after the change: | |
375,030,000 shares of common stock authorized, $0.001 par value 10,000,000 shares of preferred stock authorized, $0.001 par value | |
5. The number of shares of each affected class or series, if any, to be issued after the change in exchange for each issue share of the same class or series: | |
Not applicable. | |
6. The provisions, if any, for the issuance of fractional shares, or for the payment of money or the issuance of scrip to stockholders otherwise entitled to a fraction of a share and the percentage of outstanding shares affected thereby: | |
Fractions of shares resulting from the split will be rounded up to the next whole share. | |
7. Effective date of filing (optional): Date: February 11, 2016 Time: 6:00 AM EDT | |
8. Officer Signature: X /s/ Authorized Signature Title: Chief Executive Officer |